Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 5/20 | 0.55 |
| ▸ | CCND1 | P24385 | 5/20 | 0.55 |
| ▸ | CDK5 | Q00535 | 4/20 | 0.55 |
| ▸ | CDK5R1 | Q15078 | 4/20 | 0.55 |
| ▸ | CCNB2 | O95067 | 3/20 | 0.55 |
| ▸ | CCNE2 | O96020 | 3/20 | 0.55 |
| ▸ | CDK1 | P06493 | 3/20 | 0.55 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.55 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.55 |
| ▸ | CDK2 | P24941 | 3/20 | 0.55 |
| ▸ | CCNB3 | Q8WWL7 | 3/20 | 0.55 |
| ▸ | CAMK2B | Q13554 | 3/20 | 0.55 |
| ▸ | CAMK2G | Q13555 | 3/20 | 0.55 |
| ▸ | CAMK2D | Q13557 | 3/20 | 0.55 |
| ▸ | CAMK2A | Q9UQM7 | 3/20 | 0.55 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.55 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.55 |
| ▸ | EIF2AK2 | P19525 | 1/20 | 0.55 |
| ▸ | CDK9 | P50750 | 1/20 | 0.55 |
| ▸ | GABRP | O00591 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12003777 | 0.90 | AR (0.58) | CDK4CCND1CDK5CDK5R1CCNB2 | |
| SCHEMBL1899929 | 0.90 | CDK4 (0.57) | CDK4CCND1CDK5CDK5R1CCNB2 | |
| SCHEMBL29385634 | 0.84 | GABRP (0.67) | CDK4CCND1CDK5CDK5R1CCNB2 | |
| SCHEMBL31677103 | 0.84 | GABRP (0.67) | CDK4CCND1CDK5CDK5R1CCNB2 | |
| SCHEMBL532386 | 0.84 | GABRP (0.67) | CDK4CCND1CDK5CDK5R1CCNB2 | |
| SCHEMBL29831925 | 0.84 | GABRP (0.67) | CDK4CCND1CDK5CDK5R1CCNB2 | |
| Ammonia Solution, Strong SCHEMBL28374490 | 0.82 | GABRP (0.64) | CDK4CCND1CDK5CDK5R1CCNB2 | |
| SCHEMBL18435754 | 0.82 | GABRP (0.70) | CDK4CCND1CDK5CDK5R1CCNB2 | |
| SCHEMBL30324458 | 0.82 | GABRP (0.70) | CDK4CCND1CDK5CDK5R1CCNB2 | |
| SCHEMBL26543398 | 0.81 | CDK4 (0.56) | CDK4CCND1CDK5CDK5R1CCNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10840457-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2020-11-17 | — | — | US | disclosed |
| US-20180269405-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-09-20 | — | — | US | disclosed |
| WO-2017052099-A1 | COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2017-03-30 | — | — | WO | disclosed |
| WO-2017052099-A1 | COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2017-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10840457-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | PIEZO1, OR10J3, OCIAD1 | CDK4 2164/4885CCND1 835/4885CDK5 3929/4885 |
| US-20180269405-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, OR10J3, OCIAD1 | CDK4 2164/4885CCND1 835/4885CDK5 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.